Xiongpeng Zhu

Summary

Country: China

Publications

  1. ncbi [Construction of recombinant adenovirus vector containing human survivin gene and its expression in dendritic cells]
    Xiong Peng Zhu
    Fujian Institute of Hematology, Union Hospital, Fujian Medical University, Fuzhou 350001, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:791-4. 2006
  2. ncbi [Induction of anti-lymphoma cytotoxic T cell effect by dendritic cells transfected with recombinant adenovirus vectors carrying survivin gene]
    Xiong Peng Zhu
    Department of Hematology, The Affiliated Quanzhou First Hospital, Fujian Medical University, Quanzhou 362000, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 15:591-3. 2007
  3. ncbi In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells
    Xiong Peng Zhu
    Department of Hematology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujiang 362000, China
    Chin Med J (Engl) 121:2180-4. 2008
  4. ncbi Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
    Xiongpeng Zhu
    Department of Hematology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, 362000, China
    J Hematol Oncol 3:17. 2010

Detail Information

Publications4

  1. ncbi [Construction of recombinant adenovirus vector containing human survivin gene and its expression in dendritic cells]
    Xiong Peng Zhu
    Fujian Institute of Hematology, Union Hospital, Fujian Medical University, Fuzhou 350001, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:791-4. 2006
    ..It is concluded that the recombinant adenovirus vector containing human survivin was constructed successfully, which may provide preliminary laboratory evidence for anti-leukemia immunotherapy...
  2. ncbi [Induction of anti-lymphoma cytotoxic T cell effect by dendritic cells transfected with recombinant adenovirus vectors carrying survivin gene]
    Xiong Peng Zhu
    Department of Hematology, The Affiliated Quanzhou First Hospital, Fujian Medical University, Quanzhou 362000, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 15:591-3. 2007
    ..It is concluded that DCs transfected with Ad-survivin can induce CTL response in vitro against lymphoma cells...
  3. ncbi In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells
    Xiong Peng Zhu
    Department of Hematology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujiang 362000, China
    Chin Med J (Engl) 121:2180-4. 2008
    ....
  4. ncbi Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights
    Xiongpeng Zhu
    Department of Hematology, First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, 362000, China
    J Hematol Oncol 3:17. 2010
    ..This review also summarizes the updates of the clinical trials on novel agents including voreloxin, AS1413, behenoylara-C, ARRY520, ribavirin, AZD1152, AZD6244, and terameprocol (EM-1421) from the 2009 ASH annual meeting...